Current View:

This content is provided by Chambers. Learn more about our methodology


Assaf Oz was the lead partner acting for SK Capital on the Israeli aspects of a USD60 million financing round relating to its acquisition of Perrigo's active pharmaceutical ingredients division. Peers are pleased to see him on the other side of a transaction. One noted: "Every time we've worked with him it's been a good experience."